Inventor
RICCI ANTONIO
CH59 patents
⚠️ This page may combine multiple inventors who share the name “RICCI ANTONIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
27 patentsUS12209091B2Jan 28, 2025
Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers
HOFFMANN LA ROCHE7 citations85
US8618296B2Dec 31, 2013
Arylethynyl derivatives
HOFFMANN LA ROCHE4 citations74
US8513273B2Aug 20, 2013
Arylethynyl derivatives
HOFFMANN LA ROCHE4 citations74
US9695128B2Jul 4, 2017
Ethynyl derivatives
HOFFMANN LA ROCHE4 citations73
US9682959B2Jun 20, 2017
Ethynyl derivatives
HOFFMANN LA ROCHE2 citations73
US8969338B2Mar 3, 2015
Ethynyl derivatives
HOFFMANN LA ROCHE4 citations73
US8716316B2May 6, 2014
Positive allosteric modulators (PAM)
HOFFMANN LA ROCHE4 citations73
US12344613B2Jul 1, 2025
EGFR inhibitor for the treatment of cancer
HOFFMANN LA ROCHE3 citations72
US11708354B2Jul 25, 2023
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
HOFFMANN LA ROCHE3 citations72
US11117890B2Sep 14, 2021
Substituted isoindole allosteric EGFR inhibitors
HOFFMANN LA ROCHE3 citations72
US10882848B2Jan 5, 2021
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
HOFFMANN LA ROCHE3 citations72
US10189848B2Jan 29, 2019
Ethynyl derivatives
HOFFMANN LA ROCHE4 citations72
US10065956B2Sep 4, 2018
Ethynyl derivatives
HOFFMANN LA ROCHE4 citations72
US9725416B2Aug 8, 2017
Ethynyl derivatives
HOFFMANN LA ROCHE4 citations72
US9359301B2Jun 7, 2016
Ethynyl derivatives
HOFFMANN LA ROCHE2 citations63
US9315498B2Apr 19, 2016
Arlethynyl derivatives
HOFFMANN LA ROCHE2 citations63
US12195413B2Jan 14, 2025
Ethynyl derivatives
HOFFMANN LA ROCHE0 citations62
US12145940B2Nov 19, 2024
Ethynyl derivatives
HOFFMANN LA ROCHE0 citations62
US12006323B2Jun 11, 2024
Ethynyl derivatives
HOFFMANN LA ROCHE0 citations62
US11242349B2Feb 8, 2022
Ethynyl derivatives
HOFFMANN LA ROCHE1 citations62
US11059766B2Jul 13, 2021
Ethynyl derivatives
HOFFMANN LA ROCHE0 citations62
US11034699B2Jun 15, 2021
Ethynyl derivatives
HOFFMANN LA ROCHE0 citations62
US12479849B2Nov 25, 2025
EGFR inhibitors for the treatment of cancer
HOFFMANN LA ROCHE0 citations60
US12552801B2Feb 17, 2026
Indazole derivatives
HOFFMANN LA ROCHE0 citations59
US9751856B2Sep 5, 2017
Ethynyl derivatives
HOFFMANN LA ROCHE1 citations52
US9328070B2May 3, 2016
Ethynyl derivatives
HOFFMANN LA ROCHE0 citations52
US9227959B2Jan 5, 2016
Ethynyl derivatives
HOFFMANN LA ROCHE0 citations52
DIESSE DIAGNOSTICA
9 patentsUS6387327B1May 14, 2002
Apparatus for the preparation and the performance of sedimentation velocity tests on organic liquids and other substances
DIESSE DIAGNOSTICA23 citations91
US5420018AMay 30, 1995
Device for the preservation and analysis of samples, in particular for bacteriological examinations, isolation of micro-organisms and development of isolation colonies, and a method for seeding the samples onto a culture medium in said device
DIESSE DIAGNOSTICA13 citations74
US5133208AJul 28, 1992
Apparatus for the preparation and execution of tests on the sedimentation rate of organic liquids and other
DIESSE DIAGNOSTICA18 citations74
US6773675B2Aug 10, 2004
Test tube for biological analyses of organic liquids using electro-optical equipment
DIESSE DIAGNOSTICA5 citations72
US4774056ASep 27, 1988
Apparatus for testing sedimentation rates of liquids
DIESSE DIAGNOSTICA13 citations69
US5244637ASep 14, 1993
Test tube for biological analyses, provided with a device for checking efficiency and position, for photometric readings
DIESSE DIAGNOSTICA17 citations67
US5073719ADec 17, 1991
Apparatus for the evaluation of the erythrosedimentation rate and other
DIESSE DIAGNOSTICA6 citations63
US4379850AApr 12, 1983
Hemolytic method for the kinetic determination of antistreptolysin O antibodies in blood or serum samples, using oxidized streptolysin O
DIESSE DIAGNOSTICA4 citations63
US6190615B1Feb 20, 2001
Test tube for biological analyses of organic liquids using electro-optical equipment
DIESSE DIAGNOSTICA4 citations61
FRESENIUS KABI IPSUM S R L
5 patentsUS10414830B2Sep 17, 2019
Crystalline forms of per-chloro-γ-cyclodextrines
FRESENIUS KABI IPSUM S R L2 citations68
US10414829B2Sep 17, 2019
Process for the preparation of sugammadex and its intermediates
FRESENIUS KABI IPSUM S R L2 citations68
US10577433B2Mar 3, 2020
Process for the preparation of sugammadex
FRESENIUS KABI IPSUM S R L1 citations58
US12098218B2Sep 24, 2024
Process for the manufacture of degarelix and its intermediates
FRESENIUS KABI IPSUM S R L0 citations54
US11168114B2Nov 9, 2021
Process for the manufacture of degarelix and its intermediates
FRESENIUS KABI IPSUM S R L0 citations54
C4 THERAPEUTICS INC
3 patentsUS12371442B2Jul 29, 2025
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC1 citations74
US11673902B2Jun 13, 2023
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC3 citations72
US12486290B2Dec 2, 2025
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC0 citations62
GREEN LUKE
2 patentsJAESCHKE GEORG
2 patentsRICCI ANTONIO
1 patentSCLAVO INST SIEROTERAPEUT
1 patentShowing the top 50 of 59 patents by PatentIndex Score.